研究者
J-GLOBAL ID：201801015387571464
更新日: 2024年12月25日
増田 光治
MASUDA Mitsuharu
所属機関・部署：
職名：
助教
競争的資金等の研究課題 (5件)：
- 2019 - 2021 RB活性化能を有するがん予防成分を応用した動脈硬化予防戦略
- 2018 - 2021 がん抑制遺伝子の異常を狙い撃つ、新たながん予防戦略
- 2015 - 2019 がんの「分子標的予防法」のヒト予防介入試験への応用
- 2015 - 2017 がん予防介入研究における喫煙による増悪機序の解明
- 2013 - 2015 分子標的癌予防の実用化に向けて;安全かつ効果的な癌予防ジュースの創製の試み
論文 (23件)：
-
Yosuke Ota, Yukihiro Itoh, Yuri Takada, Yasunobu Yamashita, Chenliang Hu, Mano Horinaka, Yoshihiro Sowa, Mitsuharu Masuda, Toshiyuki Sakai, Takayoshi Suzuki. Design, synthesis, and biological evaluation of phenylcyclopropylamine-entinostat conjugates that selectively target cancer cells. Bioorganic & medicinal chemistry. 2024. 100. 117632-117632
-
Yukihiro Itoh, Peng Zhan, Toshifumi Tojo, Pattaporn Jaikhan, Yosuke Ota, Miki Suzuki, Ying Li, Zi Hui, Yukiko Moriyama, Yuri Takada, et al. Discovery of Selective Histone Deacetylase 1 and 2 Inhibitors: Screening of a Focused Library Constructed by Click Chemistry, Kinetic Binding Analysis, and Biological Evaluation. Journal of medicinal chemistry. 2023. 66. 22. 15171-15188
-
Mitsuharu Masuda, Mano Horinaka, Shusuke Yasuda, Mie Morita, Emi Nishimoto, Hideki Ishikawa, Michihiro Mutoh, Toshiyuki Sakai. Discovery of cancer-preventive juices reactivating RB functions. Environmental health and preventive medicine. 2023. 28. 54-54
-
Yosuke Ota, Yukihiro Itoh, Takashi Kurohara, Ritesh Singh, Elghareeb E Elboray, Chenliang Hu, Farzad Zamani, Anirban Mukherjee, Yuri Takada, Yasunobu Yamashita, et al. Cancer-Cell-Selective Targeting by Arylcyclopropylamine-Vorinostat Conjugates. ACS medicinal chemistry letters. 2022. 13. 10. 1568-1573
-
Motoki Watanabe, Shogen Boku, Kaito Kobayashi, Yoichi Kurumida, Mamiko Sukeno, Mitsuharu Masuda, Katsura Mizushima, Chikage Kato, Yosuke Iizumi, Kiichi Hirota, et al. A chemoproteoinformatics approach demonstrates that aspirin increases sensitivity to MEK inhibition by directly binding to RPS5. PNAS nexus. 2022. 1. 2. pgac059
もっと見る
MISC (28件)：
-
増田 光治, 堀中 真野, 安田 周祐, 森田 美枝, 西幹 栄美, 石川 秀樹, 武藤 倫弘, 酒井 敏行. RB再活性化ジュースの発見(Discovery of RB-reactivating juices). 日本癌学会総会記事. 2023. 82回. 1439-1439
-
Itoh, Yukihiro, Zhan, Peng, Tojo, Toshifumi, Jaikhan, Pattaporn, Ota, Yosuke, Suzuki, Miki, Li, Yin, Hui, Zi, Moriyama, Yukiko, Oba, Makoto, et al. Discovery of Selective Histone Deacetylase 1 and 2 Inhibitors: Screening of a Focused Library Constructed by Click Chemistry, Kinetic Binding Analysis, and Biological Evaluation. Journal of Medicinal Chemistry. 2023
-
Mitsuharu Masuda, Mano Horinaka, Shusuke Yasuda, Mie Morita, Emi Nishimoto, Hideki Ishikawa, Michihiro Mutoh, Toshiyuki Sakai. Discovery of cancer-preventive juices reactivating RB functions. Environmental Health and Preventive Medicine. 2023. 28. 54-54
-
Motoki Watanabe, Shogen Boku, Kaito Kobayashi, Yoichi Kurumida, Mamiko Sukeno, Mitsuharu Masuda, Katsura Mizushima, Chikage Kato, Yosuke Iizumi, Kiichi Hirota, et al. A chemoproteoinformatics approach demonstrates that aspirin increases sensitivity to MEK inhibition by directly binding to RPS5. PNAS Nexus. 2022. 1. 2
-
Ota, Yosuke, Itoh, Yukihiro, Kurohara, Takashi, Singh, Ritesh, Elboray, Elghareeb, Hu, Chenliang, Zamani, Farzad, Mukherjee, Anirban, Takada, Yuri, Yamashita, Yasunobu, et al. Cancer Cell-Selective Targeting by Arylcyclopropylamine-Vorinostat Conjugates. ACS Medicinal Chemistry Letters. 2022
もっと見る
学位 (1件)：
前のページに戻る
